Q1 2021

Filed Aug 20, 2021 · 10-Q · 51 days after period end · 0001640334-21-002005

Q1 2021 · 10-Q

Revenue—

Net Income

-$370.01K

N/M vs Q1 2020

EPS Diluted

$0.00

— vs Q1 2020

Gross Profit$213,003−15.9%

Operating Income-$370,085N/M

Same quarter

Metric	Q1 2021	Q1 2020	Q1 2019	Q1 2018
Revenue	—	—	$0.00	$0.00
Net Income	-$370.01K	-$31.95K	-$34.00K	-$45.00K
EPS Diluted	$0.00	$0.00	-$0.03	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR